Glycated Albumin Assay Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Human Glycated Albumin Assay, Animal Glycated Albumin Assay); Application (Diagnostics, Research); End User (Hospital, Diagnostic Centers, Research Centers, Others)

Report Code: TIPRE00019611 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Albumin is the most common protein found in serum, and glycated albumin assay monitors diabetes complications by showing damage to proteins in the last 2-3 weeks. The comparison of glycated albumin to total albumin allows calculation of a glycation index over a monthly test period.

MARKET DYNAMICS

The glycated albumin assay market is driving due to increasing prevalence of diabetes, and increasing number of product launches. However, lack of adoption in low-income countries is expected to hamper the growth of the global glycated albumin assay market. Moreover, advantages offered by glycated albumin assay over glycated hemoglobin is anticipated to drive demand the growth of the market.

MARKET SCOPE

The "Glycated Albumin Assay Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of glycated albumin assay market with detailed market segmentation by product type, application and end-user. The glycated albumin assay market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in glycated albumin assay market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The glycated albumin assay market is segmented based on product type, application and end-user. Based on product type, the market is segmented into human glycated albumin assay and animal glycated albumin assay. Based on application, the market is segmented into diagnostics, and research. Based on diagnostics, the market is segmented into Type 1 diabetes, and Type 2 diabetes. Based on end user, the market is segmented into hospital, diagnostic centers, research centers, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the glycated albumin assay market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Glycated Albumin Assay market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting glycated albumin assay market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social, and technological factors effecting the glycated albumin assay market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the glycated albumin assay market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from glycated albumin assay market are anticipated to have lucrative growth opportunities in the future with the rising demand for glycated albumin assay market in the global market. Below mentioned is the list of few companies engaged in the glycated albumin assay market.

The report also includes the profiles of key players in glycated albumin assay market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Asahi Kasei Pharma Corporation
  •   Diazyme Laboratories, Inc.
  •   LifeSpan BioSciences, Inc
  •   Geno Technology Inc., USA
  •   Epinex Diagnostics Inc
  •   DxGen
  •   EKF Diagnostics
  •   CUSABIO TECHNOLOGY LLC
  •   Abnova Corporation
  •   Ethos Biosciences, Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Glycated Albumin Assay Market - By Product Type
1.3.2 Glycated Albumin Assay Market - By Application
1.3.3 Glycated Albumin Assay Market - By End User
1.3.4 Glycated Albumin Assay Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. GLYCATED ALBUMIN ASSAY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. GLYCATED ALBUMIN ASSAY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. GLYCATED ALBUMIN ASSAY MARKET - GLOBAL MARKET ANALYSIS
6.1. GLYCATED ALBUMIN ASSAY - GLOBAL MARKET OVERVIEW
6.2. GLYCATED ALBUMIN ASSAY - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. GLYCATED ALBUMIN ASSAY MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. HUMAN GLYCATED ALBUMIN ASSAY
7.3.1. Overview
7.3.2. Human Glycated Albumin Assay Market Forecast and Analysis
7.4. ANIMAL GLYCATED ALBUMIN ASSAY
7.4.1. Overview
7.4.2. Animal Glycated Albumin Assay Market Forecast and Analysis
8. GLYCATED ALBUMIN ASSAY MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. DIAGNOSTICS
8.3.1. Overview
8.3.2. Diagnostics Market Forecast and Analysis
8.3.3. Type 1 Diabetes Market
8.3.3.1. Overview
8.3.3.2. Type 1 Diabetes Market Forecast and Analysis
8.3.4. Type 2 Diabetes Market
8.3.4.1. Overview
8.3.4.2. Type 2 Diabetes Market Forecast and Analysis
8.4. RESEARCH
8.4.1. Overview
8.4.2. Research Market Forecast and Analysis
9. GLYCATED ALBUMIN ASSAY MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL
9.3.1. Overview
9.3.2. Hospital Market Forecast and Analysis
9.4. DIAGNOSTIC CENTERS
9.4.1. Overview
9.4.2. Diagnostic Centers Market Forecast and Analysis
9.5. RESEARCH CENTERS
9.5.1. Overview
9.5.2. Research Centers Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. GLYCATED ALBUMIN ASSAY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Glycated Albumin Assay Market Overview
10.1.2 North America Glycated Albumin Assay Market Forecasts and Analysis
10.1.3 North America Glycated Albumin Assay Market Forecasts and Analysis - By Product Type
10.1.4 North America Glycated Albumin Assay Market Forecasts and Analysis - By Application
10.1.5 North America Glycated Albumin Assay Market Forecasts and Analysis - By End User
10.1.6 North America Glycated Albumin Assay Market Forecasts and Analysis - By Countries
10.1.6.1 United States Glycated Albumin Assay Market
10.1.6.1.1 United States Glycated Albumin Assay Market by Product Type
10.1.6.1.2 United States Glycated Albumin Assay Market by Application
10.1.6.1.3 United States Glycated Albumin Assay Market by End User
10.1.6.2 Canada Glycated Albumin Assay Market
10.1.6.2.1 Canada Glycated Albumin Assay Market by Product Type
10.1.6.2.2 Canada Glycated Albumin Assay Market by Application
10.1.6.2.3 Canada Glycated Albumin Assay Market by End User
10.1.6.3 Mexico Glycated Albumin Assay Market
10.1.6.3.1 Mexico Glycated Albumin Assay Market by Product Type
10.1.6.3.2 Mexico Glycated Albumin Assay Market by Application
10.1.6.3.3 Mexico Glycated Albumin Assay Market by End User
10.2. EUROPE
10.2.1 Europe Glycated Albumin Assay Market Overview
10.2.2 Europe Glycated Albumin Assay Market Forecasts and Analysis
10.2.3 Europe Glycated Albumin Assay Market Forecasts and Analysis - By Product Type
10.2.4 Europe Glycated Albumin Assay Market Forecasts and Analysis - By Application
10.2.5 Europe Glycated Albumin Assay Market Forecasts and Analysis - By End User
10.2.6 Europe Glycated Albumin Assay Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Glycated Albumin Assay Market
10.2.6.1.1 Germany Glycated Albumin Assay Market by Product Type
10.2.6.1.2 Germany Glycated Albumin Assay Market by Application
10.2.6.1.3 Germany Glycated Albumin Assay Market by End User
10.2.6.2 France Glycated Albumin Assay Market
10.2.6.2.1 France Glycated Albumin Assay Market by Product Type
10.2.6.2.2 France Glycated Albumin Assay Market by Application
10.2.6.2.3 France Glycated Albumin Assay Market by End User
10.2.6.3 Italy Glycated Albumin Assay Market
10.2.6.3.1 Italy Glycated Albumin Assay Market by Product Type
10.2.6.3.2 Italy Glycated Albumin Assay Market by Application
10.2.6.3.3 Italy Glycated Albumin Assay Market by End User
10.2.6.4 Spain Glycated Albumin Assay Market
10.2.6.4.1 Spain Glycated Albumin Assay Market by Product Type
10.2.6.4.2 Spain Glycated Albumin Assay Market by Application
10.2.6.4.3 Spain Glycated Albumin Assay Market by End User
10.2.6.5 United Kingdom Glycated Albumin Assay Market
10.2.6.5.1 United Kingdom Glycated Albumin Assay Market by Product Type
10.2.6.5.2 United Kingdom Glycated Albumin Assay Market by Application
10.2.6.5.3 United Kingdom Glycated Albumin Assay Market by End User
10.2.6.6 Rest of Europe Glycated Albumin Assay Market
10.2.6.6.1 Rest of Europe Glycated Albumin Assay Market by Product Type
10.2.6.6.2 Rest of Europe Glycated Albumin Assay Market by Application
10.2.6.6.3 Rest of Europe Glycated Albumin Assay Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Glycated Albumin Assay Market Overview
10.3.2 Asia-Pacific Glycated Albumin Assay Market Forecasts and Analysis
10.3.3 Asia-Pacific Glycated Albumin Assay Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Glycated Albumin Assay Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Glycated Albumin Assay Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Glycated Albumin Assay Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Glycated Albumin Assay Market
10.3.6.1.1 Australia Glycated Albumin Assay Market by Product Type
10.3.6.1.2 Australia Glycated Albumin Assay Market by Application
10.3.6.1.3 Australia Glycated Albumin Assay Market by End User
10.3.6.2 China Glycated Albumin Assay Market
10.3.6.2.1 China Glycated Albumin Assay Market by Product Type
10.3.6.2.2 China Glycated Albumin Assay Market by Application
10.3.6.2.3 China Glycated Albumin Assay Market by End User
10.3.6.3 India Glycated Albumin Assay Market
10.3.6.3.1 India Glycated Albumin Assay Market by Product Type
10.3.6.3.2 India Glycated Albumin Assay Market by Application
10.3.6.3.3 India Glycated Albumin Assay Market by End User
10.3.6.4 Japan Glycated Albumin Assay Market
10.3.6.4.1 Japan Glycated Albumin Assay Market by Product Type
10.3.6.4.2 Japan Glycated Albumin Assay Market by Application
10.3.6.4.3 Japan Glycated Albumin Assay Market by End User
10.3.6.5 South Korea Glycated Albumin Assay Market
10.3.6.5.1 South Korea Glycated Albumin Assay Market by Product Type
10.3.6.5.2 South Korea Glycated Albumin Assay Market by Application
10.3.6.5.3 South Korea Glycated Albumin Assay Market by End User
10.3.6.6 Rest of Asia-Pacific Glycated Albumin Assay Market
10.3.6.6.1 Rest of Asia-Pacific Glycated Albumin Assay Market by Product Type
10.3.6.6.2 Rest of Asia-Pacific Glycated Albumin Assay Market by Application
10.3.6.6.3 Rest of Asia-Pacific Glycated Albumin Assay Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Glycated Albumin Assay Market Overview
10.4.2 Middle East and Africa Glycated Albumin Assay Market Forecasts and Analysis
10.4.3 Middle East and Africa Glycated Albumin Assay Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Glycated Albumin Assay Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Glycated Albumin Assay Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Glycated Albumin Assay Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Glycated Albumin Assay Market
10.4.6.1.1 South Africa Glycated Albumin Assay Market by Product Type
10.4.6.1.2 South Africa Glycated Albumin Assay Market by Application
10.4.6.1.3 South Africa Glycated Albumin Assay Market by End User
10.4.6.2 Saudi Arabia Glycated Albumin Assay Market
10.4.6.2.1 Saudi Arabia Glycated Albumin Assay Market by Product Type
10.4.6.2.2 Saudi Arabia Glycated Albumin Assay Market by Application
10.4.6.2.3 Saudi Arabia Glycated Albumin Assay Market by End User
10.4.6.3 U.A.E Glycated Albumin Assay Market
10.4.6.3.1 U.A.E Glycated Albumin Assay Market by Product Type
10.4.6.3.2 U.A.E Glycated Albumin Assay Market by Application
10.4.6.3.3 U.A.E Glycated Albumin Assay Market by End User
10.4.6.4 Rest of Middle East and Africa Glycated Albumin Assay Market
10.4.6.4.1 Rest of Middle East and Africa Glycated Albumin Assay Market by Product Type
10.4.6.4.2 Rest of Middle East and Africa Glycated Albumin Assay Market by Application
10.4.6.4.3 Rest of Middle East and Africa Glycated Albumin Assay Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Glycated Albumin Assay Market Overview
10.5.2 South and Central America Glycated Albumin Assay Market Forecasts and Analysis
10.5.3 South and Central America Glycated Albumin Assay Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Glycated Albumin Assay Market Forecasts and Analysis - By Application
10.5.5 South and Central America Glycated Albumin Assay Market Forecasts and Analysis - By End User
10.5.6 South and Central America Glycated Albumin Assay Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Glycated Albumin Assay Market
10.5.6.1.1 Brazil Glycated Albumin Assay Market by Product Type
10.5.6.1.2 Brazil Glycated Albumin Assay Market by Application
10.5.6.1.3 Brazil Glycated Albumin Assay Market by End User
10.5.6.2 Argentina Glycated Albumin Assay Market
10.5.6.2.1 Argentina Glycated Albumin Assay Market by Product Type
10.5.6.2.2 Argentina Glycated Albumin Assay Market by Application
10.5.6.2.3 Argentina Glycated Albumin Assay Market by End User
10.5.6.3 Rest of South and Central America Glycated Albumin Assay Market
10.5.6.3.1 Rest of South and Central America Glycated Albumin Assay Market by Product Type
10.5.6.3.2 Rest of South and Central America Glycated Albumin Assay Market by Application
10.5.6.3.3 Rest of South and Central America Glycated Albumin Assay Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL GLYCATED ALBUMIN ASSAY MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. GLYCATED ALBUMIN ASSAY MARKET, KEY COMPANY PROFILES
13.1. ASAHI KASEI PHARMA CORPORATION
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. DIAZYME LABORATORIES, INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. LIFESPAN BIOSCIENCES, INC
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. GENO TECHNOLOGY INC., USA
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. EPINEX DIAGNOSTICS INC
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. DXGEN
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. EKF DIAGNOSTICS
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. CUSABIO TECHNOLOGY LLC
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. ABNOVA CORPORATION
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ETHOS BIOSCIENCES, INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Asahi Kasei Pharma Corporation
2. Diazyme Laboratories, Inc.
3. LifeSpan BioSciences, Inc
4. Geno Technology Inc., USA
5. Epinex Diagnostics Inc
6. DxGen
7. EKF Diagnostics
8. CUSABIO TECHNOLOGY LLC
9. Abnova Corporation
10. Ethos Biosciences, Inc.
TIPRE00019611
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking